Signaling Pathways - IRAK - ETA Receptors - NTPDases - Calcium-Activated Potassium (KCa) Channels
清除全部
- B7113 PSB 06126Target: NTPDasesSummary: NTPDase 3抑制剂
- B6872 IRL-2500Target: ETA Receptors|ETB ReceptorsSummary: 内皮素受体拮抗剂
- B2191 Dequalinium Chloride中文名: 地喹氯铵Target: PKC|Calcium-Activated Potassium (KCa) ChannelsSummary: PKC抑制剂
- B2075 Ambrisentan中文名: 安贝生坦Target: ETA ReceptorsSummary: ETA受体拮抗剂
- A5354 Zonisamide中文名: 唑尼沙胺Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) ChannelsSummary: 抗惊厥和机械效应的抗癫痫药
- A1888 TRAM-34Target: Calcium-Activated Potassium (KCa) ChannelsSummary: KCa3.1阻断剂
- A3505 IRAK-1-4 Inhibitor I3 CitationTarget: IRAKSummary: IRAK-1/4抑制剂
- A3504 IRAK inhibitor 6Target: IRAKSummary: IRAK-4抑制剂
- A3503 IRAK inhibitor 4Target: IRAKSummary: IRAK抑制剂
- A3502 IRAK inhibitor 3Target: IRAKSummary: IRAK抑制剂